Table 2.

Summary counts of CDEK data

Organization type	Count	API type	Count	Trial phase	Count
Academic/hospital	9495	Small molecules	13 169	Phase 2	32 538
For profit	6577	Biologics	2583	Phase 1	23 656
Individual	3634	Botanicals	1769	Phase 3	22 641
Unknown	3183	Vaccine	1698	N/A	18 830
Foundation	1200	Cell therapy	1521	Phase 4	18 267
Government	658	Biological	1182	Phase 1/Phase 2	7054
Total Orgs	24 747	Animal product	233	Phases 2/Phase 3	3184
		Gene therapy	157	Early Phase 1	1163
		Total APIs	22 312	Total Trials	127 333